购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空

Vorinostat

Rating icon 很棒
产品编号 T1583Cas号 149647-78-9
别名 伏立诺他, suberoylanilide hydroxamic acid, SAHA, MK0683

Vorinostat (SAHA) 是一种泛的组蛋白脱乙酰酶 (HDAC) 抑制剂 (IC50=10 nM),对 HDAC1/2/3/6/7/11 均有抑制活性。 Vorinostat 具有抗肿瘤活性,可以诱导细胞分化,阻滞细胞周期,诱导细胞凋亡。

Vorinostat
TargetMol

为众多的药物研发团队赋能,

让新药发现更简单!

Vorinostat

Rating icon 很棒
纯度: 99.93%
产品编号 T1583 别名 伏立诺他, suberoylanilide hydroxamic acid, SAHA, MK0683Cas号 149647-78-9

Vorinostat (SAHA) 是一种泛的组蛋白脱乙酰酶 (HDAC) 抑制剂 (IC50=10 nM),对 HDAC1/2/3/6/7/11 均有抑制活性。 Vorinostat 具有抗肿瘤活性,可以诱导细胞分化,阻滞细胞周期,诱导细胞凋亡。

规格价格库存数量
50 mg¥ 326现货
200 mg¥ 817现货
500 mg¥ 1,223现货
1 g¥ 1,785现货
1 mL x 10 mM (in DMSO)¥ 134现货
大包装 & 定制
加入购物车
实验操作小课堂
查看更多

"Vorinostat"的相关化合物库

选择批次:
纯度:99.93%
联系我们获取更多批次信息
TargetMol 的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。

产品介绍

生物活性
产品描述
Vorinostat (SAHA) is a pan-histone deacetylase (HDAC) inhibitor (IC50=10 nM) with inhibitory activity against HDAC1/2/3/6/7/11. Vorinostat has antitumor activity, induces cell differentiation, blocks the cell cycle and induces apoptosis.
靶点活性
HDAC:~10 nM (cell free)
体外活性
方法:滑膜肉瘤细胞 SW-982 和软骨肉瘤细胞 SW-1353 用 Vorinostat (0.5-15 μM) 处理 48 h,使用 MST assay 检测细胞活力。
结果:Vorinostat 以剂量依赖的方式抑制 SW-982 和 SW-1353 细胞增殖,IC50 分别为 8.6 μM 和 2.0 μM。[1]
方法:子宫肉瘤细胞 MES-SA 用 Vorinostat (3 μM) 处理 24-72 h,使用 Western Blot 方法检测靶点蛋白表达水平。
结果:在整个处理期间,HDAC1 的表达没有差异。HDAC2、3 和 7 显示出 Vorinostat 对表达的显著抑制。[2]
体内活性
方法:为检测体内抗肿瘤活性,将 Vorinostat (50 mg/kg in HOP-β-CD) 腹腔注射给携带子宫肉瘤 MES-SA 的 Nude-Foxn1nu/nu 小鼠,每周五次,持续二十一天。
结果:与安慰剂组相比,Vorinostat 治疗组观察到肿瘤生长减少了 50% 以上。[1]
方法:为研究在真性红细胞增多症 (PV) 动物模型中的作用,将 Vorinostat (200 mg/kg in 50% PEG-400) 腹腔注射给 MxCre;Jak2V617F/+ 小鼠,每周五次,持续两周。
结果:Vorinostat 治疗使 Jak2V617F 敲除小鼠的外周血计数正常化,并显著减少脾肿大。Vorinostat 可能对 PV 和其他 JAK2V617F 相关的骨髓增生性肿瘤具有治疗潜力。[3]
细胞实验
Cells were plated onto 100-mm tissue culture plates at a density of 2 × 10^6 for 48 h and then treated with SAHA or equal concentrations of the vehicle. For longer drug exposure times, medium with drug or vehicle were exchanged every 48 h. For wash-out experiments, cells were treated with SAHA daily for 60–72 h (drug and medium were exchanged at 48 h), then SAHA was washed out and replaced with 10% FCS containing DMEM [3].
动物实验
Athymic Nude-Foxn1nu/nu mice were used in the present study. They were housed at 22°C at a constant light-dark cycle (12-h light, 12-h dark) and had free access to water and rodent chow (4-5% fat, 21% protein). Twelve weeks old male mice (n = 14) were anesthetized with Isofluran and 5 × 10^6 MES-SA cells were injected subcutaneously into the right flank of the animal. Mice from a control group received placebo containing 300 μl of empty HOP-β-CD (2-hydroxypropyl-β-cyclodextrin) vesicles. Another group of mice received vorinostat dissolved in HOP-β-CD at a concentration of 50 mg/kg/day. Both, empty vesicles and vorinostat were administered intraperitoneally, starting on the day 4 after the injection of MES-SA tumor cells. Mice body weight and tumor size (w2 × l × 0.52; measured by caliper) were estimated twice a week. All mice were treated for 21 days and afterward sacrificed by cervical dislocation. Each tumor was isolated as a whole and different tumor parameters (weight, volume, size, and macroscopic appearance) were determined. Finally, tumor slices were cryopreserved and formalin fixed (4%) for further analyses [1].
别名伏立诺他, suberoylanilide hydroxamic acid, SAHA, MK0683
化学信息
分子量264.32
分子式C14H20N2O3
CAS No.149647-78-9
SmilesN(C(CCCCCCC(NO)=O)=O)C1=CC=CC=C1
密度1.174 g/cm3
储存&溶解度
存储Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度信息
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 12.5 mg/mL (47.29 mM), Suspension. Please add co-solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately.
Ethanol: 2 mg/mL (7.6 mM)
DMSO: 125 mg/mL (472.90 mM), Sonication is recommended.
溶液配制表
1mg5mg10mg50mg
1 mM3.7833 mL18.9165 mL37.8329 mL189.1646 mL
5 mM0.7567 mL3.7833 mL7.5666 mL37.8329 mL
1mg5mg10mg50mg
10 mM0.3783 mL1.8916 mL3.7833 mL18.9165 mL
20 mM0.1892 mL0.9458 mL1.8916 mL9.4582 mL
1mg5mg10mg50mg
50 mM0.0757 mL0.3783 mL0.7567 mL3.7833 mL
100 mM0.0378 mL0.1892 mL0.3783 mL1.8916 mL

计算器

  • 摩尔浓度 计算器
  • 稀释 计算器
  • 配液 计算器
  • 分子量 计算器

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
TargetMol | Animal experiments比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μLTargetMol | Animal experiments 一共给药动物 10 只 ,您使用的配方为 5% TargetMol | reagent DMSO+ 30%PEG300+ 5%Tween 80 + 60% ddH2O. 那么您的工作液浓度为 2 mg/mL
母液配置方法: 2 mg 药物溶于 50 μLDMSOTargetMol | reagent ( 母液浓度为 40 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:50μLDMSOTargetMol | reagent 母液,添加 300 μLPEG300TargetMol | reagent 混匀澄清,再加 50μLTween 80, 混匀澄清,再加 600μLddH2OTargetMol | reagent 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

1 请输入动物实验的基本信息
mg/kg
g
μL
2 请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
%Tween 80
%ddH2O

剂量转换

对于不同动物的给药剂量换算,您也可以参考 更多

关键词

评论列表

4个月前
5.0
Rating icon 很棒

评论内容

Related Tags: buy Vorinostat | purchase Vorinostat | Vorinostat cost | order Vorinostat | Vorinostat chemical structure | Vorinostat in vivo | Vorinostat in vitro | Vorinostat formula | Vorinostat molecular weight